Government Context
Documents
Following
Sign in
Documents
Documents by topic
Documents by agency
Following
Sign in
Details
Dockets
›
Requests that the FDA determine and permit ANDA applicants for Ubrogepant tablets, (50 mg and 100 mg) to submit section viii statements for Orange Book-listed U.S. Patents and associated dosage strengths and use codes listed.
›
Citizen Petition from Spencer Fane LLP
Citizen Petition from Spencer Fane LLP
Nonrulemaking
Other
FDA-2026-P-5992-0001
Pharmaceutical Policy
🔔 Subscribe
Document
Details
The document's own metadata, straight from regulations.gov.
Posted
May 27, 2026
Agency
Food and Drug Administration (FDA)
